<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://pharmoniq.com/news/fda-warning-florida-supplement-manufacturer-sanitation-allergen-violations</loc>
    <news:news>
      <news:publication>
        <news:name>PharmoniQ</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-17T14:10:49.900Z</news:publication_date>
      <news:title>FDA Warning Targets Florida Supplement Maker Over Safety Violations</news:title>
      <news:keywords>FDA enforcement, supplement safety, manufacturing violations, allergen contamination, cGMP compliance</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://pharmoniq.com/news/acp-calls-fda-premarket-safety-review-dietary-supplements</loc>
    <news:news>
      <news:publication>
        <news:name>PharmoniQ</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-16T14:10:49.072Z</news:publication_date>
      <news:title>ACP Demands FDA Premarket Review of Supplements in Major Policy Shift</news:title>
      <news:keywords>FDA regulation, DSHEA, supplement safety, ACP, premarket approval</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://pharmoniq.com/news/fda-approves-leqembi-at-home-dosing-alzheimer-treatment</loc>
    <news:news>
      <news:publication>
        <news:name>PharmoniQ</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-16T08:47:02.974Z</news:publication_date>
      <news:title>FDA Approves At-Home Dosing for Leqembi Alzheimer&apos;s Treatment</news:title>
      <news:keywords>FDA, Alzheimer&apos;s, Leqembi, disease-modifying treatment, regulatory approval</news:keywords>
    </news:news>
  </url>
</urlset>